EMIR OTC derivative reporting

Will you be ready in time?

The mammoth task of reporting OTC derivative transactions has moved a huge step closer with the authorisation of four trade repositories by the European Securities and Markets Authority (ESMA). This is the final leg of a very long process.

In this article, Fiona Syer from our Deloitte EMEA Centre for Regulatory Strategy gives an update on the current status, outlines some of the deadlines firms need to be aware of, as well as highlighs some actions they can take to in order to get ready to meet the requirements.

For further information with respect to EMIR in Belgium, please contact Caroline Veris or Nicolas Castelein.

Did you find this useful?